{"id":"W2895587415","doi":"10.3389/fphar.2018.01093","title":"The Pioglitazone Trek via Human PPAR Gamma: From Discovery to a Medicine at the FDA and Beyond","year":2018,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; Fondation Leducq","keywords":"Pioglitazone; Thiazolidinedione; Medicine; Rosiglitazone; Adverse effect; Pharmacology; Insulin resistance; Type 2 diabetes; Glucose homeostasis; Clinical trial; Bioinformatics; Diabetes mellitus; Internal medicine; Endocrinology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005389592,0.0005745181,0.001131637,0.0001438721,0.0004059052,0.0000362864,0.0008346917,0.000556739,0.00008969106],"category_scores_gemma":[0.00008248742,0.0003226695,0.0001950519,0.0002720692,0.001122621,0.00000876422,0.0007239661,0.0005245067,0.00002169082],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002355228,"about_ca_system_score_gemma":0.0001392169,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006025798,"about_ca_topic_score_gemma":0.0001197749,"domain_scores_codex":[0.9968868,0.0007510238,0.0006613047,0.0009104661,0.0001843777,0.0006060549],"domain_scores_gemma":[0.9987314,0.0001378871,0.0003160009,0.0005810739,0.00005157922,0.0001820125],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002736145,0.00007061427,0.0001658052,0.0003422359,0.001312412,0.00001873947,0.0002375835,8.215355e-7,0.03247446,0.000005782516,0.7922514,0.1728465],"study_design_scores_gemma":[0.0007462653,0.0003370331,0.000006757627,0.0002012345,0.0005039909,0.00002237113,0.00007892905,0.000002597407,0.007895206,0.0001110196,0.9897331,0.0003615178],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008734396,0.9841874,0.0002809115,0.0006548214,0.004493026,0.00115012,0.0001534529,0.00001347531,0.0003323799],"genre_scores_gemma":[0.0005964346,0.9925356,0.0001484534,0.0009792842,0.002278319,0.0005175452,0.000482852,0.0000891369,0.002372355],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1974817,"threshold_uncertainty_score":0.9999225,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01501392434510712,"score_gpt":0.3245149973397092,"score_spread":0.3095010729946021,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}